These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17948981)

  • 21. A novel and potent VLA-4 antagonist based on trans-4-substituted cyclohexanecarboxylic acid.
    Muro F; Iimura S; Yoneda Y; Chiba J; Watanabe T; Setoguchi M; Takayama G; Yokoyama M; Takashi T; Nakayama A; Machinaga N
    Bioorg Med Chem; 2009 Feb; 17(3):1232-43. PubMed ID: 19124247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R).
    Pelletier JC; Chengalvala MV; Cottom JE; Feingold IB; Green DM; Hauze DB; Huselton CA; Jetter JW; Kopf GS; Lundquist JT; Magolda RL; Mann CW; Mehlmann JF; Rogers JF; Shanno LK; Adams WR; Tio CO; Wrobel JE
    J Med Chem; 2009 Apr; 52(7):2148-52. PubMed ID: 19271735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteinase-activated receptor-2 mediates the expression of integrin alpha5 and beta1 in Helicobacter pylori-infected gastric epithelial AGS cells.
    Seo JH; Lim JW; Yoon JH; Kim H
    Digestion; 2009; 80(1):40-9. PubMed ID: 19478484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Sulfonyl-benzimidazoles as selective CB2 agonists.
    Verbist BM; De Cleyn MA; Surkyn M; Fraiponts E; Aerssens J; Nijsen MJ; Gijsen HJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2574-9. PubMed ID: 18394887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of orally bioavailable benzimidazoles as Raf kinase inhibitors.
    Ramurthy S; Subramanian S; Aikawa M; Amiri P; Costales A; Dove J; Fong S; Jansen JM; Levine B; Ma S; McBride CM; Michaelian J; Pick T; Poon DJ; Girish S; Shafer CM; Stuart D; Sung L; Renhowe PA
    J Med Chem; 2008 Nov; 51(22):7049-52. PubMed ID: 18942827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-guided design of substituted aza-benzimidazoles as potent hypoxia inducible factor-1alpha prolyl hydroxylase-2 inhibitors.
    Frohn M; Viswanadhan V; Pickrell AJ; Golden JE; Muller KM; Bürli RW; Biddlecome G; Yoder SC; Rogers N; Dao JH; Hungate R; Allen JR
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5023-6. PubMed ID: 18755588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of new benzimidazole-coumarin conjugates as anti-hepatitis C virus agents.
    Hwu JR; Singha R; Hong SC; Chang YH; Das AR; Vliegen I; De Clercq E; Neyts J
    Antiviral Res; 2008 Feb; 77(2):157-62. PubMed ID: 17977606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The alpha4beta1 integrin in sickle cell disease.
    Brittain JE; Parise LV
    Transfus Clin Biol; 2008; 15(1-2):19-22. PubMed ID: 18501656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and SAR of N-benzoyl-L-biphenylalanine derivatives: discovery of TR-14035, a dual alpha(4)beta(7)/alpha(4)beta(1) integrin antagonist.
    Sircar I; Gudmundsson KS; Martin R; Liang J; Nomura S; Jayakumar H; Teegarden BR; Nowlin DM; Cardarelli PM; Mah JR; Connell S; Griffith RC; Lazarides E
    Bioorg Med Chem; 2002 Jun; 10(6):2051-66. PubMed ID: 11937364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation.
    Thimmegowda NR; Nanjunda Swamy S; Kumar CS; Kumar YC; Chandrappa S; Yip GW; Rangappa KS
    Bioorg Med Chem Lett; 2008 Jan; 18(1):432-5. PubMed ID: 17981032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid.
    Setoguchi M; Iimura S; Sugimoto Y; Yoneda Y; Chiba J; Watanabe T; Muro F; Iigo Y; Takayama G; Yokoyama M; Taira T; Aonuma M; Takashi T; Nakayama A; Machinaga N
    Bioorg Med Chem; 2013 Jan; 21(1):42-61. PubMed ID: 23218775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic study of VLA-4/VCAM-1 inhibitors: synthesis and structure-activity relationship of piperazinylphenylalanine derivatives.
    Saku O; Ohta K; Arai E; Nomoto Y; Miura H; Nakamura H; Fuse E; Nakasato Y
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1053-7. PubMed ID: 18160288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological activity evaluation of 1H-benzimidazoles via mammalian DNA topoisomerase I and cytostaticity assays.
    Coban G; Zencir S; Zupkó I; Réthy B; Gunes HS; Topcu Z
    Eur J Med Chem; 2009 May; 44(5):2280-5. PubMed ID: 18692939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2,6-Quinolinyl derivatives as potent VLA-4 antagonists.
    Lassoie MA; Broeders F; Collart P; Defrère L; de Laveleye-Defais F; Demaude T; Gassama A; Guillaumet G; Hayez JC; Kiss L; Knerr L; Nicolas JM; Norsikian S; Quéré L; Routier S; Verbois V; Provins L
    Bioorg Med Chem Lett; 2007 Jan; 17(1):142-6. PubMed ID: 17035017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
    Hu L; Kully ML; Boykin DW; Abood N
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3374-7. PubMed ID: 19481935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small molecule antagonists of the gonadotropin-releasing hormone (GnRH) receptor: structure-activity relationships of small heterocyclic groups appended to the 2-phenyl-4-piperazinyl-benzimidazole template.
    Hauze DB; Chengalvala MV; Cottom JE; Feingold IB; Garrick L; Green DM; Huselton C; Kao W; Kees K; Lundquist JT; Mann CW; Mehlmann JF; Rogers JF; Shanno L; Wrobel J; Pelletier JC
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1986-90. PubMed ID: 19251413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent benzimidazolone-based CGRP receptor antagonists.
    Theberge CR; Bednar RA; Bell IM; Corcoran HA; Fay JF; Hershey JC; Johnston VK; Kane SA; Mosser S; Salvatore CA; Williams TM; Zartman CB; Zhang XF; Graham SL; Vacca JP
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6122-5. PubMed ID: 18947992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvicine inactivates beta 1 integrin and inhibits adhesion of MDA-MB-435 cells to fibronectin via reactive oxygen species signaling.
    Zhou J; Chen Y; Lang JY; Lu JJ; Ding J
    Mol Cancer Res; 2008 Feb; 6(2):194-204. PubMed ID: 18314480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuated translocation of group IVa phospholipase A2 and up-regulated annexin-1 synthesis by glucocorticoid blocks beta 2-integrin adhesion in neutrophils.
    Meliton AY; Munoz NM; Zhu X; Leff AR
    J Leukoc Biol; 2008 Feb; 83(2):344-51. PubMed ID: 17971499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches.
    Fritzsche J; Simonis D; Bendas G
    Thromb Haemost; 2008 Dec; 100(6):1166-75. PubMed ID: 19132244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.